PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $564,410 | -36.3% | 67,594 | +1.4% | 0.01% | -28.6% |
Q2 2023 | $886,565 | +23.0% | 66,659 | +7.1% | 0.01% | +16.7% |
Q1 2023 | $720,739 | +46.2% | 62,240 | +3.3% | 0.01% | +20.0% |
Q4 2022 | $493,025 | +46.7% | 60,272 | +4.0% | 0.01% | +66.7% |
Q3 2022 | $336,000 | +33.3% | 57,927 | +1.7% | 0.00% | +50.0% |
Q2 2022 | $252,000 | -51.2% | 56,944 | +0.5% | 0.00% | -50.0% |
Q1 2022 | $516,000 | -50.4% | 56,650 | +11.3% | 0.00% | -50.0% |
Q4 2021 | $1,041,000 | -20.7% | 50,882 | -0.9% | 0.01% | -27.3% |
Q3 2021 | $1,312,000 | -24.8% | 51,333 | +2.9% | 0.01% | -21.4% |
Q2 2021 | $1,744,000 | +1.1% | 49,866 | -3.7% | 0.01% | -6.7% |
Q1 2021 | $1,725,000 | +39.1% | 51,776 | +8.3% | 0.02% | +36.4% |
Q4 2020 | $1,240,000 | +152.5% | 47,800 | -3.9% | 0.01% | +120.0% |
Q3 2020 | $491,000 | +358.9% | 49,732 | +60.0% | 0.01% | +150.0% |
Q2 2020 | $107,000 | +15.1% | 31,087 | +1.8% | 0.00% | 0.0% |
Q1 2020 | $93,000 | – | 30,538 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HAVENS ADVISORS LLC | 638,000 | $4,613,000 | 4.46% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 6,064,035 | $43,843,000,000 | 3.34% |
STANSBERRY ASSET MANAGEMENT, LLC | 1,022,262 | $7,391,000 | 2.54% |
HighVista Strategies LLC | 378,479 | $2,736,000 | 2.23% |
Versor Investments LP | 3,117,632 | $22,540,000 | 2.14% |
BARDIN HILL MANAGEMENT PARTNERS LP | 1,627,677 | $11,768,000 | 1.84% |
ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $8,030,000 | 1.71% |
Magnetar Financial LLC | 8,217,938 | $59,416,000 | 1.53% |
ALPINE ASSOCIATES MANAGEMENT INC. | 6,072,459 | $43,905,000 | 1.45% |
WATER ISLAND CAPITAL LLC | 7,247,354 | $52,398,000 | 1.43% |